|
Subject
|
Erythema
|
Induration
|
Local pain*
|
Itch
|
|---|
|
No. 1
|
V32 →
|
V32 →
|
V32 →
|
-
|
|
No. 2
|
V16 →
|
-
|
-
|
-
|
|
No. 3
|
V22 →
|
V23 →
|
V22
|
-
|
|
No. 4
|
V25 →
|
V25 →
|
-
|
-
|
|
No. 5
|
V29 →
|
V29 →
|
-
|
-
|
|
No. 6
|
V26 →
|
V26 →
|
-
|
V26 →
|
|
No. 7
|
V22 →
|
V22 →
|
V22
|
V31 →
|
|
No. 8
|
V13 →
|
V13 →
|
-
|
V8/16/25; V27 →
|
|
No. 9
|
V9 →
|
V9 →
|
V17 →-
|
V9
|
|
episodes total No. (per 306 injections)
|
101 (33%)
|
95 (31%)
|
27 (8.8%)
|
30 (9.8%)
|
|
episodes/subject [median No., range]
|
12 (1-26)
|
10 (0-25)
|
n.a.
|
n.a.
|
|
average size [cm, range]
|
2.5 (2-11)
|
3.0 (0-11)
|
n.a.
|
n.a.
|
- V32 → = after visit 32 and every following visit; V22 = after visit 22; * = mild in character; n.a. = not applicable
